The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 04, 2015

Filed:

Aug. 24, 2011
Applicants:

Crystal M. Cunanan, Mission Viejo, CA (US);

John Joseph Higgins, Palmerston North, NZ;

Saroja Nagaraj Guradzada, Palmerston North, NZ;

Inventors:

Crystal M. Cunanan, Mission Viejo, CA (US);

John Joseph Higgins, Palmerston North, NZ;

Saroja Nagaraj Guradzada, Palmerston North, NZ;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61F 2/02 (2006.01); A61F 2/24 (2006.01); A61L 27/36 (2006.01); A61L 27/50 (2006.01); A61L 31/00 (2006.01); A61K 35/34 (2015.01);
U.S. Cl.
CPC ...
A61F 2/2412 (2013.01); A61F 2/2427 (2013.01); A61L 27/3604 (2013.01); A61L 27/507 (2013.01); A61L 31/005 (2013.01); A61K 35/34 (2013.01); A61L 2430/40 (2013.01); Y10S 623/918 (2013.01);
Abstract

Biomaterials with enhanced properties such as improved strength, flexibility, durability and reduced thickness are useful in the fabrication of biomedical devices, particularly those subjected to continuous or non-continuous loads where repeated flexibility and long-term durability are required. These enhanced properties can be attributed to elevated levels of elastin, altered collagen types, and other biochemical changes which contribute to these enhanced properties. Examples of devices which would be improved by use of such tissue include heart valves, including percutaneous heart valves, and vascular grafts, patches and the like. Such enhanced materials can be sourced from specific populations of animals, such as neonatal calves, or in range-fed adult cattle, or can be fabricated or created from cell populations exhibiting such properties. In one embodiment, glutaraldehyde-fixed neonatal pericardial tissue is used to create leaflets in a percutaneous heart valve, and may be used without chemical fixation, with or without processes to remove residual cellular membranes, and utilized as a scaffold material for tissue engineering.


Find Patent Forward Citations

Loading…